Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lactulose Combined With PEG-ELS for Bowel Preparation in Type II Diabetes Mellitus
NCT07084350Completed
- Sponsor
- General Hospital of the Northern Theater Command
- Start
- Sep 2025
- Primary completion
- May 2026
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Randomised trial of lactulose in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by General Hospital of the Northern Theater Command. Primary endpoint: Adequate Bowel Preparation Rate at 3 days. Started Sep 2025; status: completed.
02
Drugs
lactulose
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT07084350.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07084350.